Thalidomide in Treating Patients With Thyroid Cancer
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Thalidomide may stop the growth of thyroid cancer by stopping blood flow to the
tumor.
PURPOSE: Phase II trial to study the effectiveness thalidomide in treating patients who have
thyroid cancer.